The U.S. Food and Drug Administration (FDA) is overhauling its approach to post-market oversight of food chemicals, marked by the proposed rollout of a new Post-Market Assessment Prioritization Tool. The FDA first announced...more
7/1/2025
/ Chemicals ,
Food and Drug Administration (FDA) ,
Food Manufacturers ,
Food Safety ,
GRAS ,
Proposed Rules ,
Public Health ,
REACH ,
Regulatory Oversight ,
Regulatory Reform ,
Risk Assessment ,
Rulemaking Process ,
Toxic Chemicals ,
Toxic Substances Control Act (TSCA)
The Make America Healthy Again (MAHA) Commission, as established by President Donald Trump's Feb. 13, 2025, Executive Order (EO) 14212, released its inaugural report on May 22, 2025, titled "The MAHA Report: Making Our...more
5/27/2025
/ Artificial Intelligence ,
Chemicals ,
Clinical Trials ,
Environmental Protection Agency (EPA) ,
Food and Drug Administration (FDA) ,
Food Manufacturers ,
Food Supply ,
Information Reports ,
Pesticides ,
Prescription Drugs ,
Public Health ,
Regulatory Reform ,
Toxic Chemicals ,
Trump Administration
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
3/21/2025
/ Centers for Disease Control and Prevention (CDC) ,
CMMI ,
Continuing Resolution ,
Department of Health and Human Services (HHS) ,
Executive Orders ,
Health Information Technologies ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Office of Personnel Management (OPM) ,
Pending Legislation ,
Policy Updates ,
Public Health ,
Regulatory Agenda ,
Regulatory Requirements ,
Tariffs ,
Trump Administration ,
World Health Organization
U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced on March 10, 2025, that he directed the acting commissioner of the U.S. Food and Drug Administration (FDA) to explore potential...more
Dr. Jayanta (Jay) Bhattacharya, nominated to be Director of the National Institutes of Health (NIH), and Dr. Martin Makary, nominated to be the Commissioner of the U.S. Food and Drug Administration (FDA), appeared before the...more
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
3/5/2025
/ Administrative Procedure Act ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Executive Orders ,
Federal Funding ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medical Research ,
Medicare ,
Medicare Advantage ,
New Legislation ,
Pharmacy Benefit Manager (PBM) ,
Public Health ,
Regulatory Agenda ,
Regulatory Requirements ,
Senate Confirmation Hearings ,
Tariffs
Holland & Knight Health Dose Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/26/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Department of Government Efficiency (DOGE) ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health ,
Regulatory Agenda ,
Regulatory Requirements ,
Tariffs
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/20/2025
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Controlled Substances ,
DEA ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Public Health ,
Regulatory Agenda ,
Senate Confirmation Hearings
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/6/2025
/ Department of Health and Human Services (HHS) ,
Executive Orders ,
Federal Funding ,
Freeze Order ,
Health Care Providers ,
Healthcare ,
Legislative Agendas ,
New Legislation ,
Public Health ,
Regulatory Agenda ,
Senate Confirmation Hearings ,
Tariffs
Although Robert F. Kennedy Jr.'s nomination hearings to be the Secretary of the U.S. Department of Health and Human Services (HHS) focused on a variety of areas, his testimony and questions from U.S. senators focused on a few...more
2/4/2025
/ Clinical Trials ,
Department of Health and Human Services (HHS) ,
Draft Guidance ,
Drug Safety ,
Food and Drug Administration (FDA) ,
National Institute of Health (NIH) ,
Presidential Nominations ,
Public Health ,
Regulatory Agenda ,
Senate Confirmation Hearings ,
Vaccinations
Holland & Knight Health Dose Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
1/23/2025
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Constitutional Challenges ,
Department of Health and Human Services (HHS) ,
Federal Trade Commission (FTC) ,
Health Information Technologies ,
Health Insurance ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
MedPAC ,
New Legislation ,
Public Health ,
Regulatory Agenda ,
SCOTUS ,
Telemedicine ,
Trump Administration